Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative
Clinical trial NCT05113186 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05113186
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-02
- Primary completion
- 2025-06-19
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.